vs
Side-by-side financial comparison of MAGNACHIP SEMICONDUCTOR Corp (MX) and Phathom Pharmaceuticals, Inc. (PHAT). Click either name above to swap in a different company.
Phathom Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($57.6M vs $40.6M, roughly 1.4× MAGNACHIP SEMICONDUCTOR Corp). On growth, Phathom Pharmaceuticals, Inc. posted the faster year-over-year revenue change (94.1% vs -20.7%). MAGNACHIP SEMICONDUCTOR Corp produced more free cash flow last quarter ($-4.8M vs $-167.0M).
Magnachip Semiconductor Corp is a global semiconductor design and manufacturing firm specializing in high-performance analog and mixed-signal solutions. Its core products include display driver ICs, power management ICs and sensors, serving consumer electronics, automotive, industrial and communications markets worldwide.
Phathom Pharmaceuticals is a clinical-stage biopharmaceutical firm focused on developing and commercializing innovative therapies for gastrointestinal diseases. Its lead product candidates address acid-related disorders, inflammatory bowel disease, and other GI conditions, serving patients mainly across North America and Europe.
MX vs PHAT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $40.6M | $57.6M |
| Net Profit | $-8.1M | — |
| Gross Margin | 9.3% | 86.7% |
| Operating Margin | -26.1% | — |
| Net Margin | -19.9% | — |
| Revenue YoY | -20.7% | 94.1% |
| Net Profit YoY | 50.4% | 71.6% |
| EPS (diluted) | $-0.23 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $40.6M | $57.6M | ||
| Q3 25 | $45.9M | $49.5M | ||
| Q2 25 | $47.6M | $39.5M | ||
| Q1 25 | $44.7M | $28.5M | ||
| Q4 24 | $51.2M | $29.7M | ||
| Q3 24 | $55.4M | $16.4M | ||
| Q2 24 | $46.4M | $7.3M | ||
| Q1 24 | $43.4M | — |
| Q4 25 | $-8.1M | — | ||
| Q3 25 | $-13.1M | $-30.0M | ||
| Q2 25 | $323.0K | $-75.8M | ||
| Q1 25 | $-8.9M | $-94.3M | ||
| Q4 24 | $-16.3M | — | ||
| Q3 24 | $-9.6M | $-85.6M | ||
| Q2 24 | $-13.0M | $-91.4M | ||
| Q1 24 | $-15.4M | — |
| Q4 25 | 9.3% | 86.7% | ||
| Q3 25 | 18.6% | 87.5% | ||
| Q2 25 | 20.4% | 87.2% | ||
| Q1 25 | 20.9% | 86.9% | ||
| Q4 24 | 21.7% | 87.1% | ||
| Q3 24 | 20.8% | 85.6% | ||
| Q2 24 | 21.1% | 81.2% | ||
| Q1 24 | 14.6% | — |
| Q4 25 | -26.1% | — | ||
| Q3 25 | -25.1% | -30.8% | ||
| Q2 25 | -15.6% | -151.7% | ||
| Q1 25 | -14.1% | -276.5% | ||
| Q4 24 | -12.5% | — | ||
| Q3 24 | -8.1% | -433.0% | ||
| Q2 24 | -12.3% | -1055.4% | ||
| Q1 24 | -21.6% | — |
| Q4 25 | -19.9% | — | ||
| Q3 25 | -28.5% | -60.5% | ||
| Q2 25 | 0.7% | -191.9% | ||
| Q1 25 | -19.9% | -330.7% | ||
| Q4 24 | -31.8% | — | ||
| Q3 24 | -17.3% | -523.3% | ||
| Q2 24 | -28.0% | -1248.6% | ||
| Q1 24 | -35.5% | — |
| Q4 25 | $-0.23 | — | ||
| Q3 25 | $-0.36 | $-0.41 | ||
| Q2 25 | $0.01 | $-1.05 | ||
| Q1 25 | $-0.24 | $-1.31 | ||
| Q4 24 | $-0.44 | — | ||
| Q3 24 | $-0.26 | $-1.32 | ||
| Q2 24 | $-0.34 | $-1.56 | ||
| Q1 24 | $-0.40 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $103.8M | $130.0M |
| Total DebtLower is stronger | — | $209.1M |
| Stockholders' EquityBook value | $248.3M | $-438.2M |
| Total Assets | $351.5M | $259.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $103.8M | $130.0M | ||
| Q3 25 | $108.0M | $135.2M | ||
| Q2 25 | $113.3M | $149.6M | ||
| Q1 25 | $132.7M | $212.3M | ||
| Q4 24 | $138.6M | $297.3M | ||
| Q3 24 | $151.1M | $334.7M | ||
| Q2 24 | $162.5M | $276.2M | ||
| Q1 24 | $171.6M | — |
| Q4 25 | — | $209.1M | ||
| Q3 25 | — | $207.1M | ||
| Q2 25 | — | $205.1M | ||
| Q1 25 | — | $203.2M | ||
| Q4 24 | — | $201.4M | ||
| Q3 24 | — | $175.7M | ||
| Q2 24 | — | $174.4M | ||
| Q1 24 | — | — |
| Q4 25 | $248.3M | $-438.2M | ||
| Q3 25 | $255.3M | $-422.5M | ||
| Q2 25 | $270.2M | $-405.8M | ||
| Q1 25 | $269.2M | $-338.4M | ||
| Q4 24 | $276.8M | $-253.6M | ||
| Q3 24 | $299.6M | $-187.1M | ||
| Q2 24 | $305.8M | $-233.8M | ||
| Q1 24 | $321.9M | — |
| Q4 25 | $351.5M | $259.1M | ||
| Q3 25 | $359.6M | $240.3M | ||
| Q2 25 | $370.5M | $250.2M | ||
| Q1 25 | $373.9M | $294.2M | ||
| Q4 24 | $379.3M | $378.3M | ||
| Q3 24 | $411.4M | $387.0M | ||
| Q2 24 | $412.7M | $319.4M | ||
| Q1 24 | $426.2M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.4M | $-166.8M |
| Free Cash FlowOCF − Capex | $-4.8M | $-167.0M |
| FCF MarginFCF / Revenue | -11.9% | -290.0% |
| Capex IntensityCapex / Revenue | 25.3% | 0.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-54.2M | $-328.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.4M | $-166.8M | ||
| Q3 25 | $162.0K | $-14.1M | ||
| Q2 25 | $-25.1M | $-62.7M | ||
| Q1 25 | $-4.7M | $-84.9M | ||
| Q4 24 | $11.9M | $-266.8M | ||
| Q3 24 | $-12.9M | $-63.6M | ||
| Q2 24 | $-1.1M | $-70.7M | ||
| Q1 24 | $-4.0M | — |
| Q4 25 | $-4.8M | $-167.0M | ||
| Q3 25 | $-7.5M | $-14.1M | ||
| Q2 25 | $-37.0M | $-62.8M | ||
| Q1 25 | $-4.9M | $-84.9M | ||
| Q4 24 | $4.4M | $-266.9M | ||
| Q3 24 | $-15.5M | $-63.6M | ||
| Q2 24 | $-2.0M | $-70.8M | ||
| Q1 24 | $-4.6M | — |
| Q4 25 | -11.9% | -290.0% | ||
| Q3 25 | -16.3% | -28.6% | ||
| Q2 25 | -77.7% | -159.0% | ||
| Q1 25 | -10.9% | -297.9% | ||
| Q4 24 | 8.7% | -899.8% | ||
| Q3 24 | -28.0% | -389.0% | ||
| Q2 24 | -4.3% | -966.2% | ||
| Q1 24 | -10.7% | — |
| Q4 25 | 25.3% | 0.4% | ||
| Q3 25 | 16.7% | 0.1% | ||
| Q2 25 | 24.9% | 0.2% | ||
| Q1 25 | 0.5% | 0.1% | ||
| Q4 24 | 14.5% | 0.5% | ||
| Q3 24 | 4.7% | 0.3% | ||
| Q2 24 | 1.9% | 0.6% | ||
| Q1 24 | 1.5% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -77.81× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MX
| Power Analog Solutions | $36.8M | 91% |
| Power Ic | $3.8M | 9% |
PHAT
Segment breakdown not available.
